FutureTox: Building the Road for 21st Century Toxicology and Risk Assessment
Practices—October 18–19, 2012
In just a few weeks, scientists will gather to participate in the "FutureTox:
Building the Road for 21st Century Toxicology and Risk Assessment Practices"
meeting. FutureTox will address the challenges and opportunities associated with
effective and efficient implementation of cutting-edge toxicity testing
technologies and tools that will inform hazard prediction and risk assessment.
This SOT Contemporary Concepts in Toxicology meeting will be held on October
18–19, 2012, in Arlington, Virginia. In addition to SOT, the Dow Chemical
Company, US Food and Drug Administration (US FDA), ILSI Health and Environmental
Sciences Institute Risk 21, Human Toxicology Project Consortium, and the
National Institute of Environmental Health Sciences (NIEHS) are sponsors.
FutureTox will provide information of great relevance to scientists in academia,
government, and industry.
The Organizing Committee includes James S. Bus and Craig Rowlands, The Dow
Chemical Company; Kim Boekelheide, Brown University; Russell S. Thomas, The
Hamner Institutes for Health Sciences; Vicki L. Dellarco, US Environmental
Protection Agency (US EPA); Marty Stephens, Human Toxicology Project Consortium;
George P. Daston, Procter & Gamble; Suzanne Compton Fitzpatrick, US Food and
Drug Administration; Raymond R. Tice, NIEHS; Robert J. Kavlock, US EPA; and
Laurie C. Haws, ToxStrategies.
For general information, to review the program, and to register, visit the
FutureTox website.
